Singapore’s Temasek Holdings has acquired around 3.6% of Bayer stock for €3 billion, amounting to around 31 million shares. The proceeds from the sale will contribute to the financing of Bayer’s proposed acquisition of Monsanto, an agricultural company.
On completion of the deal, together with its existing shareholdings in Bayer, Temasek will hold approximately 4% of the issued capital stock of Bayer. Bayer CEO Werner Baumann said in a statement that the deal affirms its business strategy, which includes the proposed Monsanto deal, as well as its strong growth prospects.
“We are very pleased that Temasek has significantly increased its holding in our company. Temasek takes equity positions in leading companies globally and is a long-term investor,” Baumann added.
The company most recently made headlines for its investment into Dogus Restaurant Entertainment and Management (D.ream), valued at US$1.2 billion. D.ream is known for owning Nusr-Et steakhouse, the birth of the internet’s #SaltBae meme. A Reuters report read that Temasek and Metric Capital had paid US$200 million for a 17% holding.
Last year, Temasek invested into Creative Artists Agency (CAA), a global entertainment and sports agency. According a press statement, the investment will be used to further CAA’s growth, including through acquisitions. It also led a US$502 million Series D equity funding for Magic Leap, which also saw other investors such as EDBI – the investment arm of the Singapore Economic Development Board.